Autonomix Medical to Present at 2024 CIRSE Congress
![Autonomix Medical to Present at 2024 CIRSE Congress](https://investorshangout.com/images/blog/investors-hangout-newswire.jpg)
Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation
Presentation to discuss latest developments in future AI applications in interventional radiology, specifically highlighting the early results from the Company’s ongoing proof-of-concept (PoC) human clinical trial.
Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted treatments, today announced its technology and interim clinical trial findings will be featured in a podium presentation at the 2024 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Congress being held in Lisbon.
“As we continue to execute on our clinical strategy, engaging with the scientific community is a priority and area of focus for Autonomix. We are thrilled to have received acceptance for presentation at this prestigious global congress and to be included in CIRSE’s newly added, state-of-the-art interactive area, called SPHAIRE, which is dedicated to deepening the understanding of what emerging technologies can bring to Interventional Radiology. We believe aligning the release of our data and our publication strategy is a key component of raising awareness for our innovative platform technology, and we look forward to participating in this upcoming event,” commented Brad Hauser, Chief Executive Officer of Autonomix.
Details of the Presentation
Details of the presentation are as follows:
Title: Rethinking pain management: transforming patient outcomes with precision mapping technology and celiac nerve RF ablation in end-stage cancer
Session: Future AI Applications in Interventional Radiology
Presenter: Dr. Askar Sabirov, Primary Investigator for the Company’s ongoing PoC human clinical trial in pain associated with pancreatic cancer
Session Date and Time: Monday, September 16 from 11:15 AM – 12:15 PM ET
About Autonomix Medical, Inc.
Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class technology platform includes a catheter-based microchip sensing array that can detect and differentiate neural signals with approximately 3,000 times greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.
We are initially developing this technology for the treatment of pain, with initial trials focused on pancreatic cancer, a condition that causes debilitating pain and is without a reliable solution. Our technology constitutes a platform to address dozens of indications, including cardiology, hypertension, and chronic pain management, across a wide disease spectrum. Our technology is investigational and has not yet been cleared for marketing in the United States.
For more information, visit autonomix.com and connect with the Company on X, LinkedIn, Instagram, and Facebook.
Frequently Asked Questions
What is Autonomix Medical focusing on?
Autonomix Medical is focused on advancing precision nerve-targeted treatments for diseases involving the nervous system.
What will be presented at the CIRSE Annual Congress?
The presentation will discuss innovative pain management techniques using precision mapping technology and RF ablation.
Who is the presenter for the session?
Dr. Askar Sabirov, the Primary Investigator for the ongoing PoC human clinical trial in pain associated with pancreatic cancer, will present.
When will the presentation take place?
The presentation is scheduled for Monday, September 16, from 11:15 AM to 12:15 PM ET.
What is unique about Autonomix's technology?
The technology features a catheter-based microchip sensing array that detects neural signals with significantly higher sensitivity than existing technologies.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/